ALG 072571
Alternative Names: ALG-072571Latest Information Update: 16 Aug 2023
At a glance
- Originator Aligos Therapeutics
- Class Antivirals; Small interfering RNA
- Mechanism of Action Programmed cell death 1 receptor expression inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hepatitis B